AMI Semiconductor Inc. (AMIS, Pocatello, ID), a manufacturer of application-specific integrated circuits and structured digital products, announced a technology design and supply partnership with Interventional Rhythm Management Inc. (IRM), a specialist cardiology company dedicated to the management of patients with cardiac arrhythmias and heart failure. Under the terms of the agreement, AMIS will provide custom, low-power, mixed-signal ASIC solutions that will be used in IRM’s cardiac electrophysiology devices such as implantable defibrillators and pacemakers.
The design allows defibrillators and pacemakers to be completely introduced and implanted within the vascular system without major surgery. The company’s initial product will be an Intravascular Implantable Defibrillator™ designed for the primary prevention of sudden cardiac death. A key element of this and future products will be turnkey, low-power ASIC solutions from AMIS that ensure extended battery life without compromising functionality, in addition to offering options for low-data rate wireless communications within the MICS medical communications band.
“AMIS is proud to partner with IRM to facilitate the development of its pioneering electrophysiology technology platform,” said AMI Semiconductor President and CEO Christine King. “By coming to AMIS for turnkey, mixed-signal, low-power and MICS data communications solutions, IRM has clearly demonstrated that it is not necessary to employ armies of design engineers to implement ground-breaking medical designs. We look forward to further proving the depth of our experience and helping to bring other revolutionary life-saving medical technology to market to enhance the lives of patients.”
